178 results on '"Létourneau, Myriam"'
Search Results
2. Lipidated peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as biased allosteric ligands
3. Protein context shapes the specificity of SH3 domain-mediated interactions in vivo
4. Al[18F]F-complexation of DFH17, a NOTA-conjugated adrenomedullin analog, for PET imaging of pulmonary circulation
5. Lipophilicity-antiproliferative activity relationship study leads to the preparation of a ruthenium(II) arene complex with considerable in vitro cytotoxicity against cancer cells and a lower in vivo toxicity in zebrafish embryos than clinically approved cis-platin
6. Conformational exchange divergence along the evolutionary pathway of eosinophil-associated ribonucleases
7. Optimization of on-resin palladium-catalyzed Sonogashira cross-coupling reaction for peptides and its use in a structure–activity relationship study of a class B GPCR ligand
8. A conserved SH3-like fold in diverse putative proteins tetramerizes into an oxidoreductase providing an antimicrobial resistance phenotype
9. Tunable Surface Charge Enables the Electrostatic Adsorption-Controlled Release of Neuroprotective Peptides from a Hydrogel–Nanoparticle Drug Delivery System
10. Insight into the role of urotensin II-related peptide tyrosine residue in UT activation
11. Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide
12. Supporting Information for 'A conserved SH3-like fold in diverse putative proteins tetramerises into an oxidoreductase providing an antimicrobial resistance phenotype'
13. Conformational Exchange Divergence Along the Evolutionary Pathway of Eosinophil-Associated Ribonucleases
14. Perturbing dimer interactions and allosteric communication modulates the immunosuppressive activity of human galectin-7
15. Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinsonʼs disease model
16. Tunable Surface Charge Enables the Electrostatic Adsorption-Controlled Release of Neuroprotective Peptides from a Hydrogel–Nanoparticle Drug Delivery System.
17. Photoreleasable ligands to study intracrine angiotensin II signalling
18. Characterization of the adrenomedullin receptor acting as the target of a new radiopharmaceutical biomolecule for lung imaging
19. Perturbing dimer interactions and allosteric communication modulates the immunosuppressive activity of human galectin-7
20. Dealing with the Aggregation Problem of Polyglutamine Peptides: Synthesis Strategies
21. Membrane-tethered peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as allosteric biased ligands
22. Binding of a Soluble meso-Tetraarylporphyrin to Human Galectin-7 Induces Oligomerization and Modulates Its Pro-Apoptotic Activity
23. Urocontrin, a novel UT receptor ligand with a unique pharmacological profile
24. Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects
25. Genome sequencing and functional characterization of a Dictyopanus pusillus fungal enzymatic extract offers a promising alternative for lignocellulose pretreatment of oil palm residues
26. Insights into Structural and Dynamical Changes Experienced by Human RNase 6 upon Ligand Binding
27. Genome sequencing and functional characterization of aDictyopanus pusillusfungal extract offers a promising alternative for lignocellulose pretreatment of oil palm residues
28. Design and biological assessment of membrane-tethering neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptor
29. Perturbing dimer interactions and allosteric communication modulates the immunosuppressive activity of human galectin-7.
30. Development and pharmacological characterization of “caged” urotensin II analogs
31. PTHrP fragments 1-16 and 1-23 do not bind to either the ETA or the ETB endothelin receptors
32. Semi‐rational evolution of the 3‐(3‐hydroxyalkanoyloxy)alkanoate (HAA) synthase RhlA to improve rhamnolipid production inPseudomonas aeruginosaandBurkholderia glumae
33. Antibacterial properties of the pituitary adenylate cyclase-activating polypeptide: A new human antimicrobial peptide
34. New insights about the peculiar role of the 28–38 C-terminal segment and some selected residues in PACAP for signaling and neuroprotection
35. Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activity
36. Semi‐rational evolution of the 3‐(3‐hydroxyalkanoyloxy)alkanoate (HAA) synthase RhlA to improve rhamnolipid production in Pseudomonas aeruginosa and Burkholderia glumae.
37. Effect of the pituitary adenylate cyclase-activating polypeptide on the autophagic activation observed in in vitro and in vivo models of Parkinson's disease
38. Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin
39. Molecular Imaging of the Human Pulmonary Vascular Endothelium Using an Adrenomedullin Receptor Ligand
40. How to improve PACAP efficiency for neuroprotection and neurorepair?
41. Dealing with the Aggregation Problem of Polyglutamine Peptides: Synthesis Strategies
42. Design of a Truncated Cardiotoxin-I Analogue with Potent Insulinotropic Activity
43. Development of agonists of endothelin-1 exhibiting selectivity towards ETA receptors
44. Development and Pharmacological Characterization of Conformationally Constrained Urotensin II-Related Peptide Agonists
45. MOLECULAR IMAGING OF THE HUMAN PULMONARY VASCULAR ENDOTHELIUM IN PULMONARY HYPERTENSION: THE PULMOBIND SAFETY AND PROOF OF PRINCIPLE TRIAL
46. PulmoBind, an Adrenomedullin-Based Molecular Lung Imaging Tool
47. Update on the urotensinergic system: new trends in receptor localization, activation, and drug design
48. Cardiotoxin-I: An Unexpectedly Potent Insulinotropic Agent
49. Presence of urotensin-II receptors at the cell nucleus: Specific tissue distribution and hypoxia-induced modulation
50. Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.